JP2018027099A5 - - Google Patents

Download PDF

Info

Publication number
JP2018027099A5
JP2018027099A5 JP2017216772A JP2017216772A JP2018027099A5 JP 2018027099 A5 JP2018027099 A5 JP 2018027099A5 JP 2017216772 A JP2017216772 A JP 2017216772A JP 2017216772 A JP2017216772 A JP 2017216772A JP 2018027099 A5 JP2018027099 A5 JP 2018027099A5
Authority
JP
Japan
Prior art keywords
cells
pluripotent stem
human pluripotent
stem cells
primitive ectoderm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017216772A
Other languages
English (en)
Other versions
JP6777620B2 (ja
JP2018027099A (ja
Filing date
Publication date
Priority claimed from US11/021,618 external-priority patent/US7510876B2/en
Application filed filed Critical
Publication of JP2018027099A publication Critical patent/JP2018027099A/ja
Publication of JP2018027099A5 publication Critical patent/JP2018027099A5/ja
Application granted granted Critical
Publication of JP6777620B2 publication Critical patent/JP6777620B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (16)

  1. 原始外胚葉細胞をインビトロで産生する方法であって、
    (a)ヒト多能性幹細胞に、前記ヒト多能性幹細胞が原始外胚葉細胞に分化するのを促進するのに十分な量の少なくとも一つのTGFβスーパーファミリー成長因子を提供する工程であって、前記原始外胚葉細胞は、中胚葉または胚体内胚葉に分化し得る多能性細胞である、工程、
    (b)前記原始外胚葉細胞を十分な時間生成させ、それにより原始外胚葉細胞を産生する工程
    を含む前記方法。
  2. 前記TGFβスーパーファミリー成長因子が、ノーダル、アクチビンA又はアクチビンBである、請求項1記載の方法。
  3. 前記TGFβスーパーファミリー成長因子がアクチビンAである、請求項2記載の方法。
  4. 前記ヒト多能性幹細胞に、少なくとも10ng/mlのアクチビンAが提供される、請求項3記載の方法。
  5. 前記ヒト多能性幹細胞に、少なくとも100ng/mlのアクチビンAが提供される、請求項3記載の方法。
  6. 前記ヒト多能性幹細胞がヒト胚性幹細胞である、請求項1〜5のいずれか1項に記載の方法。
  7. 前記ヒト多能性幹細胞が、桑実胚、胚の内部細胞塊(ICM)又は胚の生殖隆起に由来する、請求項1〜6のいずれか1項に記載の方法。
  8. 前記ヒト多能性幹細胞に血清を提供する工程をさらに含む、請求項1〜7のいずれか1項に記載の方法。
  9. 前記ヒト多能性幹細胞に、2%(v/v)未満の血清を含む培地を提供する工程をさらに含む、請求項1〜8のいずれか1項に記載の方法。
  10. 前記原始外胚葉細胞が、FZD10、FGF5及びOCT4から選ばれる少なくとも一つのマーカーを発現する、請求項1〜9のいずれか1項に記載の方法。
  11. 前記ヒト多能性幹細胞の少なくとも15%が前記原始外胚葉細胞に分化する、請求項1〜10のいずれか1項に記載の方法。
  12. 前記ヒト多能性幹細胞の少なくとも50%が前記原始外胚葉細胞に分化する、請求項1〜10のいずれか1項に記載の方法。
  13. 前記ヒト多能性幹細胞の少なくとも90%が前記原始外胚葉細胞に
    分化する、請求項1〜10のいずれか1項に記載の方法。
  14. 原始外胚葉細胞をインビトロで産生する方法であって、
    ヒト多能性幹細胞を含む細胞集団に、TGFβスーパーファミリー成長因子を提供し、少なくとも10%の原始外胚葉細胞を含む細胞集団を産生する工程を含む前記方法。
  15. 前記細胞集団を、血清を含まない培地で培養する、請求項14記載の方法。
  16. 前記細胞集団を、血清代替物を含まない培地で培養する、請求項14記載の方法。
JP2017216772A 2004-07-09 2017-11-09 前原始線条及び中内胚葉細胞 Active JP6777620B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US58656604P 2004-07-09 2004-07-09
US60/586,566 2004-07-09
US58794204P 2004-07-14 2004-07-14
US60/587,942 2004-07-14
US11/021,618 2004-12-23
US11/021,618 US7510876B2 (en) 2003-12-23 2004-12-23 Definitive endoderm
US69336405P 2005-06-23 2005-06-23
US60/693,364 2005-06-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016076972A Division JP6473708B2 (ja) 2004-07-09 2016-04-07 前原始線条及び中内胚葉細胞

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020068885A Division JP7161665B2 (ja) 2004-07-09 2020-04-07 前原始線条及び中内胚葉細胞

Publications (3)

Publication Number Publication Date
JP2018027099A JP2018027099A (ja) 2018-02-22
JP2018027099A5 true JP2018027099A5 (ja) 2018-04-05
JP6777620B2 JP6777620B2 (ja) 2020-10-28

Family

ID=40262947

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2007520513A Active JP5433879B2 (ja) 2004-07-09 2005-07-08 前原始線条及び中内胚葉細胞
JP2013150092A Active JP5956388B2 (ja) 2004-07-09 2013-07-19 前原始線条及び中内胚葉細胞
JP2015086989A Active JP6077044B2 (ja) 2004-07-09 2015-04-21 前原始線条及び中内胚葉細胞
JP2016076972A Active JP6473708B2 (ja) 2004-07-09 2016-04-07 前原始線条及び中内胚葉細胞
JP2017216772A Active JP6777620B2 (ja) 2004-07-09 2017-11-09 前原始線条及び中内胚葉細胞
JP2020068885A Active JP7161665B2 (ja) 2004-07-09 2020-04-07 前原始線条及び中内胚葉細胞
JP2022113855A Active JP7525102B2 (ja) 2004-07-09 2022-07-15 前原始線条及び中内胚葉細胞

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2007520513A Active JP5433879B2 (ja) 2004-07-09 2005-07-08 前原始線条及び中内胚葉細胞
JP2013150092A Active JP5956388B2 (ja) 2004-07-09 2013-07-19 前原始線条及び中内胚葉細胞
JP2015086989A Active JP6077044B2 (ja) 2004-07-09 2015-04-21 前原始線条及び中内胚葉細胞
JP2016076972A Active JP6473708B2 (ja) 2004-07-09 2016-04-07 前原始線条及び中内胚葉細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020068885A Active JP7161665B2 (ja) 2004-07-09 2020-04-07 前原始線条及び中内胚葉細胞
JP2022113855A Active JP7525102B2 (ja) 2004-07-09 2022-07-15 前原始線条及び中内胚葉細胞

Country Status (10)

Country Link
EP (2) EP1773986B1 (ja)
JP (7) JP5433879B2 (ja)
CN (1) CN102586170B (ja)
AU (1) AU2005271944B2 (ja)
CA (1) CA2573354C (ja)
DK (2) DK1773986T3 (ja)
ES (2) ES2754038T3 (ja)
MX (1) MX2007000317A (ja)
NZ (1) NZ582597A (ja)
WO (1) WO2006017134A2 (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US7541185B2 (en) 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
WO2007059007A2 (en) 2005-11-14 2007-05-24 Cythera, Inc. Markers of definitive endoderm
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
US7510876B2 (en) 2003-12-23 2009-03-31 Cythera, Inc. Definitive endoderm
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
JP5102030B2 (ja) * 2004-08-13 2012-12-19 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド ヒト胚性幹細胞における自己再生および分化のための組成物および方法
AU2005322007B2 (en) * 2004-12-23 2011-06-30 Viacyte, Inc. Expansion of definitive endoderm cells
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
DK1957636T3 (en) 2005-10-27 2018-10-01 Viacyte Inc PDX1-EXPRESSING DORSAL AND VENTRAL FORTARM ENDODERM
SG10201405107YA (en) 2006-02-23 2014-10-30 Viacyte Inc Compositions and methods useful for culturing differentiable cells
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
US11254916B2 (en) 2006-03-02 2022-02-22 Viacyte, Inc. Methods of making and using PDX1-positive pancreatic endoderm cells
EP1999253B1 (en) 2006-03-02 2019-05-22 Viacyte, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
WO2008013664A2 (en) 2006-07-26 2008-01-31 Cythera, Inc. Methods of producing pancreatic hormones
WO2008048647A1 (en) * 2006-10-17 2008-04-24 Cythera, Inc. Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells
US7695963B2 (en) 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
EP2356227B1 (en) 2008-11-14 2018-03-28 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
RU2576003C2 (ru) 2008-12-03 2016-02-27 Интернэшнл Стем Селл Корпорейшн Способ получения дифференцированных клеток из стволовых клеток
CN114173837A (zh) 2019-05-31 2022-03-11 W.L.戈尔及同仁股份有限公司 生物相容性膜复合材料
CN114206407A (zh) 2019-05-31 2022-03-18 W.L.戈尔及同仁股份有限公司 生物相容性膜复合材料
EP3976236A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. A biocompatible membrane composite
JP7328362B2 (ja) 2019-05-31 2023-08-16 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド 制御された酸素拡散距離を伴う細胞カプセル化デバイス
KR20230051519A (ko) 2020-08-15 2023-04-18 리제너론 파마슈티칼스 인코포레이티드 칼시토닌 수용체 (calcr)를 인코딩하는 변이체 핵산 분자를 갖는 대상체에서 비만의 치료

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2161804A (en) 1935-11-09 1939-06-13 Baldwin Southwark Corp Hydraulic press
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2247502A1 (en) 1996-02-28 1997-09-04 Vanderbilt University Compositions and methods of making embryonic stem cells
IL129295A0 (en) * 1996-10-07 2000-02-17 Univ Johns Hopkins Med Novel hedgehog-derived polypeptides
WO1998037195A1 (en) * 1997-02-19 1998-08-27 Regeneron Pharmaceuticals, Inc. Morphogenic proteins
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6075007A (en) * 1997-07-17 2000-06-13 Regeneron Pharmaceuticals, Inc. Modified noggin polypeptide and compositions
US6800480B1 (en) 1997-10-23 2004-10-05 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
JP2000217571A (ja) * 1999-01-29 2000-08-08 Japan Science & Technology Corp インビトロで誘導した移植用臓器
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7045353B2 (en) * 2000-08-01 2006-05-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Directed differentiation of human embryonic cells
WO2003046141A2 (en) * 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
GB2415432B (en) * 2001-12-07 2006-09-06 Geron Corp Islet cells from human embryonic stem cells
US20030235563A1 (en) * 2002-04-19 2003-12-25 Strom Stephen C. Placental derived stem cells and uses thereof
EP2361966A1 (en) * 2002-05-17 2011-08-31 Mount Sinai School of Medicine of New York University Mesoderm and definitive endoderm cell populations
US20040229350A1 (en) 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
US7510876B2 (en) * 2003-12-23 2009-03-31 Cythera, Inc. Definitive endoderm
JP5102030B2 (ja) * 2004-08-13 2012-12-19 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド ヒト胚性幹細胞における自己再生および分化のための組成物および方法
US11586805B2 (en) 2021-07-26 2023-02-21 Atlassian Pty Ltd. Machine-learning-based natural language processing techniques for low-latency document summarization

Similar Documents

Publication Publication Date Title
JP2018027099A5 (ja)
Cananzi et al. CD117+ amniotic fluid stem cells: state of the art and future perspectives
Delo et al. Amniotic fluid and placental stem cells
Bishop et al. Embryonic stem cells
Phermthai et al. A novel method to derive amniotic fluid stem cells for therapeutic purposes
Shaikh et al. Mouse bone marrow VSELs exhibit differentiation into three embryonic germ lineages and germ & hematopoietic cells in culture
Chen et al. Isolation and characterization of porcine amniotic fluid-derived multipotent stem cells
Rippon et al. Embryonic stem cells
Pappa et al. Novel sources of fetal stem cells: where do they fit on the developmental continuum?
Kehoe et al. Propagation of embryonic stem cells in stirred suspension without serum
Okeyo et al. Cell adhesion minimization by a novel mesh culture method mechanically directs trophoblast differentiation and self-assembly organization of human pluripotent stem cells
Karamzadeh et al. Dental-related stem cells and their potential in regenerative medicine
Li et al. Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitro
Bajek et al. Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine
Park et al. Comparison of human first and third trimester placental mesenchymal stem cell
Cho et al. Human feeder layer system derived from umbilical cord stromal cells for human embryonic stem cells
Virant-Klun Very small embryonic-like stem cells: a potential developmental link between germinal lineage and hematopoiesis in humans
Khanlarkhani et al. Multipotent Stem Cell and Reproduction.
Moraveji et al. Inhibition of glycogen synthase kinase-3 promotes efficient derivation of pluripotent stem cells from neonatal mouse testis
Pal et al. Assessment of pluripotency and multilineage differentiation potential of NTERA‐2 cells as a model for studying human embryonic stem cells
Kim et al. Establishment of bovine embryonic stem cell lines using a minimized feeder cell drop
Cha et al. Generation of embryonic stem‐like cells from in vivo‐derived porcine blastocysts at a low concentration of basic fibroblast growth factor
Ma et al. Isolation and biological characterization of a novel type of pulmonary mesenchymal stem cells derived from Wuzhishan miniature pig embryo
Tobias et al. Small-molecule induction of canine embryonic stem cells toward naïve pluripotency
Hamidi et al. In vitro models of pre-and post-gastrulation embryonic development